Skip to content

Eye maneuver in modulating the autonomic nervous system in academics: a randomized clinical trial

Oculomotor maneuver in autonomic modulation in academics: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8yn35p
Enrollment
Unknown
Registered
2020-08-18
Start date
2018-01-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathological Conditions

Interventions

The intervention will take place in 30 volunteers in each group. The 1st stage performed before the oculomotor maneuver was performed, with the patient at rest for 10 minutes without team intervention
Other
E02.779

Sponsors

Universidade Federal do Piauí
Lead Sponsor
Universidade Federal do Piauí
Collaborator

Eligibility

Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: The participants were healthy; aged between 18 and 30 years old; regardless of gender; who agreed to conduct the research by signing the informed consent form (ICF).

Exclusion criteria

Exclusion criteria: The individuals who reported psychiatric problems; neurological diseases; glaucoma; constant use of drugs; women in menstrual periods or pregnant women and people who were using contact lenses did not participate in the research; in addition to those who requested to withdraw from the research

Design outcomes

Primary

MeasureTime frame
It is expected that there will be a 20% reduction in blood pressure, heart and respiratory rate, and an improvement in oxygen saturation, verified by the sphygmomanometer and oximeter, respectively, from the observation of a variation of at least 5% in the measurements. pre and post intervention (intragroup and intergroup)

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactGuilherme de Morais Gouveia

Universidade Federal do Piauí

gpfatufpi@gmail.com5586999939674

Outcome results

None listed

Source: REBEC (via WHO ICTRP)